Director Jerome News Today

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on […]

Piper Sandler cut shares of Itron (NASDAQ:ITRI – Free Report) from an overweight rating to a neutral rating in a research report sent to investors on Tuesday, Marketbeat.com reports. They currently have $109.00 price target on the scientific and technical instruments company’s stock. Other equities research analysts have also recently issued research reports about the […]

PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $43.00 to $53.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. A number of other brokerages also recently weighed in on PTCT. Cantor Fitzgerald reissued […]

Shares of Itron, Inc. (NASDAQ:ITRI – Get Free Report) have received an average rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month […]

Victory Capital Management Inc. boosted its position in shares of Itron, Inc. (NASDAQ:ITRI – Free Report) by 31.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,122 shares of the scientific and technical instruments company’s stock after buying an additional 3,338 shares during the […]

Itron (NASDAQ:ITRI – Free Report) had its target price hoisted by Oppenheimer from $100.00 to $110.00 in a report released on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the scientific and technical instruments company’s stock. ITRI has been the subject of a number of other reports. Canaccord Genuity Group raised […]

Itron (NASDAQ:ITRI – Get Free Report) issued its quarterly earnings data on Thursday. The scientific and technical instruments company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.39, Briefing.com reports. The firm had revenue of $603.44 million during the quarter, compared to the consensus estimate of $579.49 […]

Itron (NASDAQ:ITRI – Get Free Report) had its price target raised by analysts at Roth Mkm from $102.00 to $112.00 in a report released on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the scientific and technical instruments company’s stock. Roth Mkm’s price objective would suggest a potential upside of 6.09% from […]

Sonen Capital LLC decreased its holdings in shares of Itron, Inc. (NASDAQ:ITRI – Free Report) by 23.5% in the 4th quarter, Holdings Channel reports. The fund owned 3,632 shares of the scientific and technical instruments company’s stock after selling 1,118 shares during the period. Sonen Capital LLC’s holdings in Itron were worth $274,000 at the […]

Itron, Inc. (NASDAQ:ITRI – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month price objective among […]